Baird Financial Group Inc. Buys 20,584 Shares of DaVita Inc. $DVA

Key Points

• Baird Financial Group Inc. significantly increased its position in DaVita Inc. by 322.9% in Q1, acquiring a total of 26,959 shares valued at $4.12 million.
• DaVita reported earnings of $2.95 EPS for the last quarter, exceeding analyst expectations of $2.70, and had a revenue of $3.38 billion.
• Analysts' price targets for DaVita range from $148.00 to $169.00, with a consensus rating of "Hold" from multiple investment firms.

Baird Financial Group Inc. increased its stake in DaVita Inc. (NYSE:DVA - Free Report) by 322.9% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 26,959 shares of the company's stock after purchasing an additional 20,584 shares during the period. Baird Financial Group Inc.'s holdings in DaVita were worth $4,124,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Doma Perpetual Capital Management LLC boosted its stake in DaVita by 172.3% in the 1st quarter. Doma Perpetual Capital Management LLC now owns 288,360 shares of the company's stock worth $44,110,000 after purchasing an additional 182,476 shares during the period. Vident Advisory LLC acquired a new position in DaVita in the 1st quarter worth $1,328,000. Te Ahumairangi Investment Management Ltd boosted its stake in DaVita by 0.4% in the 1st quarter. Te Ahumairangi Investment Management Ltd now owns 42,318 shares of the company's stock worth $6,473,000 after purchasing an additional 148 shares during the period. Iron Triangle Partners LP boosted its stake in DaVita by 22.7% in the 1st quarter. Iron Triangle Partners LP now owns 319,566 shares of the company's stock worth $48,884,000 after purchasing an additional 59,142 shares during the period. Finally, State of Wyoming boosted its stake in DaVita by 28.9% in the 1st quarter. State of Wyoming now owns 2,603 shares of the company's stock worth $398,000 after purchasing an additional 583 shares during the period. 90.12% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

DVA has been the subject of a number of research analyst reports. Truist Financial set a $148.00 target price on shares of DaVita in a research note on Friday, August 8th. Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, August 22nd. Bank of America reduced their price objective on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research note on Wednesday. Finally, Barclays reduced their price objective on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Three analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Reduce" and an average price target of $158.00.

DaVita Stock Performance

Shares of DVA stock traded up $1.06 on Thursday, reaching $133.32. The stock had a trading volume of 728,851 shares, compared to its average volume of 671,162. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The firm's 50-day moving average is $138.64 and its two-hundred day moving average is $141.60. The firm has a market capitalization of $9.53 billion, a price-to-earnings ratio of 13.11, a P/E/G ratio of 0.95 and a beta of 1.13. DaVita Inc. has a 12 month low of $126.07 and a 12 month high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.70 by $0.25. The company had revenue of $3.38 billion for the quarter, compared to analysts' expectations of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. DaVita's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, research analysts expect that DaVita Inc. will post 10.76 EPS for the current fiscal year.

Insider Activity

In other news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction dated Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the sale, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. This represents a 8.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.50% of the company's stock.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.